Thursday, July 3, 2025 7/3/2025

Protein-protein interactions and structural switching of the bifunctional Chlamydia trachomatis protein, Scc4

Award Number: R15GM109413
ORGANIZATION: NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 09/01/2014
PERIOD OF PERFORMANCE END DATE: 05/31/2026

Group Awards By:

View Award Description

Protein-protein interactions and structural switching of the bifunctional Chlamydia trachomatis protein, Scc4 - PROJECT SUMMARY The role of the bi-functional Chlamydia trachomatis protein, Scc4 (formerly Ct663), in regulating the type III se- cretion system (T3SS) and the essential, developmental cycle (between infectious elementary bodies and ac- tively dividing, reticulate bodies) is not well-understood at the molecular level. Scc4 is a unique protein that functions (i) as a T3SS chaperone with Scc1 to regulate secretion of CopN (an essential virulence factor) and (ii) as a transcription factor regulating 66-RNA polymerase holoenzyme. Based on progress made during the last funding period, the switching mechanism proposed for Scc4’s dual functions involves a conformational change in its 3-dimensional structure. Because Scc4 has two essential functions and is unique to C. tracho- matis, it is a novel target for developing anti-virulence drugs. To develop drugs targeting the C. trachomatis T3SS and developmental cycle, hit-compounds must first be identified and their effects on Scc4’s structure, protein-protein interactions, and functions characterized. The long-term goal of the proposed research is to de- velop drugs targeting Scc4’s functions, which would prevent the bacteria from spreading, likely curing C. tra- chomatis directly and certainly mitigating the development of antibiotic-resistant strains, when combined with current therapies. The overall objectives of this application are to increase our understanding of the conforma- tional changes and binding sites that regulate Scc4’s switching mechanism and protein-protein interactions. The central hypothesis is that a conformational switch in Scc4’s structure, induced by binding native ligands, regulates its dual activity. The rationale for the proposed research is that inhibitors to disrupt Scc4’s functions can be rationally designed, resulting in new approaches to treat C. trachomatis and new molecular tools to study the T3SS and developmental cycle. The central hypothesis and objectives of this application will be tested and attained by pursuing two specific aims: (1) identify small molecule ligands that bind or disrupt Scc4 and its T3SS complexes and (2) map the native protein- and small molecule-ligand binding sites on Scc4 and Scc4:Scc1 and identify allosteric effects. It is anticipated that these aims will yield the expected outcome of a structural model of ligand-binding sites on Scc4 and the Scc4:Scc1 complex from native ligands and hit-com- pounds. This outcome is expected to have an important positive impact because characterization of the protein binding sites and identification of small molecule ligands provide the information necessary to develop drugs targeting Scc4’s conformational switch or protein-protein interactions, fundamentally advancing the fields of structural biology and infectious disease biology. This contribution is significant because it is the first step in a continuum of research that is expected to lead to understanding Scc4’s dual functions at the atomic level and contribute to the treatment of the most common, sexually transmitted bacterial disease. The proposed research is innovative because the NMR structural and biochemical characterization of a unique bi-functional protein from C. trachomatis to target bacterial virulence as a therapeutic strategy represents a new and substantive departure from the status quo.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = -$41 )
2025	2023	LOUISIANA STATE UNIVERSITY	202 HIMES HALL	BATON ROUGE	LA	70803	EAST BATON ROUGE	USA	Biomedical Research and Research Training	000	3	10/1/2024	COMPETING CONTINUATION	-$41
2025	2023	LOUISIANA STATE UNIVERSITY	202 HIMES HALL	BATON ROUGE	LA	70803	EAST BATON ROUGE	USA	Biomedical Research and Research Training	001	3	2/27/2025	COMPETING CONTINUATION	-$1
2025	2023	JOHN CARROLL UNIVERSITY	1 JOHN CARROLL BLVD	CLEVELAND	OH	44118	CUYAHOGA	USA	Biomedical Research and Research Training	002	4	2/27/2025	CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION	$1
														Subtotal = -$41

Issue Date FY: 2024 ( Subtotal = -$43,543 )
2024	2023	LOUISIANA STATE UNIVERSITY	202 HIMES HALL	BATON ROUGE	LA	70803	EAST BATON ROUGE	USA	Biomedical Research and Research Training	001	3	1/5/2024	COMPETING CONTINUATION	$41
2024	2023	JOHN CARROLL UNIVERSITY	1 JOHN CARROLL BLVD	CLEVELAND	OH	44118	CUYAHOGA	USA	Biomedical Research and Research Training	003	4	2/8/2024	CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION	$387,715
2024	2023	LOUISIANA STATE UNIVERSITY	202 HIMES HALL	BATON ROUGE	LA	70803	EAST BATON ROUGE	USA	Biomedical Research and Research Training	002	3	2/7/2024	COMPETING CONTINUATION	-$431,258
2024	2019	LOUISIANA STATE UNIVERSITY	202 HIMES HALL	BATON ROUGE	LA	70803	EAST BATON ROUGE	USA	Biomedical Research and Research Training	000	2	1/5/2024	COMPETING CONTINUATION	-$41
														Subtotal = -$43,543

Issue Date FY: 2023 ( Subtotal = $431,259 )
2023	2023	LOUISIANA STATE UNIVERSITY	202 HIMES HALL	BATON ROUGE	LA	70803	EAST BATON ROUGE	USA	Biomedical Research and Research Training	001	3	5/19/2023	COMPETING CONTINUATION	$431,259
2023	2019	LOUISIANA STATE UNIVERSITY	202 HIMES HALL	BATON ROUGE	LA	70803	EAST BATON ROUGE	USA	Biomedical Research and Research Training	000	2	5/11/2023	COMPETING CONTINUATION	$0
														Subtotal = $431,259

Issue Date FY: 2019 ( Subtotal = $434,606 )
2019	2019	LOUISIANA STATE UNIVERSITY	202 HIMES HALL	BATON ROUGE	LA	70803	EAST BATON ROUGE	USA	Biomedical Research and Research Training	001	2	9/20/2019	COMPETING CONTINUATION	$434,606
2019	2014	LOUISIANA STATE UNIVERSITY	202 HIMES HALL	BATON ROUGE	LA	70803	EAST BATON ROUGE	USA	Biomedical Research and Research Training	000	1	11/17/2018	NEW	$0
														Subtotal = $434,606

Issue Date FY: 2014 ( Subtotal = $329,724 )
2014	2014	LOUISIANA STATE UNIV AND A&M COLLEGE	THOMAS BOYD HALL	BATON ROUGE	LA	70803	EAST BATON ROUGE	USA	Biomedical Research and Research Training	000	1	8/15/2014	NEW	$329,724
														Subtotal = $329,724

Grand Total All Awards = $1,152,005

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Protein-protein interactions and structural switching of the bifunctional Chlamydia trachomatis protein, Scc4

Award Number: R15GM109413

ORGANIZATION: NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 09/01/2014

PERIOD OF PERFORMANCE END DATE: 05/31/2026

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer